Opinion
Video
Jaclyn Kovach, MD, FASRS, presents the case of a patient with neovascular AMD with persistent subretinal fluid, and members of the panel share their experiences treating similar patients.
4DMT publishes preclinical data demonstrating the potential of the Therapeutic Vector Evolution (TVE) platform
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Phenocell and Amarna Therapeutics awarded Eurostars grant for continued investigation of dry AMD gene therapy platform
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Galimedix Therapeutics initiates phase 1 trial of oral GAL-101
Over 300 patients randomized in Ocular Therapeutix's SOL-1 phase 3 trial for OTX-TKI